These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4115589)

  • 21. [Long-term effects of cyclophosphamide therapy in treatment of the "primary" nephrotic syndrome of childhood].
    Lama G
    Pediatria (Napoli); 1976 Jun; 84(2):320-30. PubMed ID: 798171
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions.
    Tejani A; Phadke K; Nicastri A; Adamson O; Chen CK; Trachtman H; Tejani C
    Nephron; 1985; 41(2):170-3. PubMed ID: 4047274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.
    Webb H; Jaureguiberry G; Dufek S; Tullus K; Bockenhauer D
    Pediatr Nephrol; 2016 Apr; 31(4):589-94. PubMed ID: 26525199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
    de Moor R; de Jong M; Monnens L
    Ned Tijdschr Geneeskd; 1992 May; 136(18):876-80. PubMed ID: 1589052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Verification of indications for kidney biopsy in children with steroid-dependent nephrotic syndrome].
    Idczak-Nowicka E; Ksiazek J; Kryński J; Wyszyńska T
    Pediatr Pol; 1996 Aug; 71(8):679-83. PubMed ID: 8927471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter: Cyclophosphamide and neoplasia.
    Wood L
    Lancet; 1974 Oct; 2(7885):898-9. PubMed ID: 4137763
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclophosphamide and the nephrotic syndrome.
    Drummond KN
    Br Med J; 1969 May; 2(5656):576-7. PubMed ID: 5769897
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment with cyclophosphamide in elderly-onset nephrotic syndrome.
    Mak SK; Lo KY; Wong CY; Tong GM; Wong PN; Wong AK
    Nephron Clin Pract; 2005; 101(1):c25-32. PubMed ID: 15886494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic agents in childhood glomerulonephritis.
    Barratt M
    Arch Dis Child; 1972 Apr; 47(252):159-62. PubMed ID: 4554082
    [No Abstract]   [Full Text] [Related]  

  • 31. Stability of remission in minimal lesion nephrotic syndrome after treatment with prednisolone and cyclophosphamide.
    Dundon S; O'Callaghan U; Raftery J
    Int J Pediatr Nephrol; 1980 Mar; 1(1):22-5. PubMed ID: 7343524
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy].
    Takeda Y; Tomino Y
    Nihon Rinsho; 2004 Oct; 62(10):1875-9. PubMed ID: 15500133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Long term use of cyclophosphamide in nephrotic syndrome".
    Choudhary VP
    Indian Pediatr; 1978 Apr; 15(4):369. PubMed ID: 711307
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA; Levtchenko EN; Wetzels JF
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
    Podracká L; Böör A; Sasinka M
    Cas Lek Cesk; 2008; 147(1):38-43. PubMed ID: 18323041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
    Bajpai A; Bagga A; Hari P; Dinda A; Srivastava RN
    Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclophosphamide and the minimal change nephrotic syndrome in children.
    Thomson PD; Brown RS; Kaplan BS; Abrahams C
    S Afr Med J; 1972 Jun; 46(25):851. PubMed ID: 5076080
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclophosphamide pulse therapy in relapsing nephrotic syndrome.
    Wardle EN
    Nephron; 1991; 58(3):377. PubMed ID: 1896110
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclophosphamide in the treatment of the nephrotic syndrome in childhood.
    Spitzer A
    Pediatrics; 1972 Sep; 50(3):358-60. PubMed ID: 5056408
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclophosphamide in minimal-change nephrotic syndrome.
    Rizvi SN; Vaishnava H
    Lancet; 1972 Jul; 2(7770):229. PubMed ID: 4114232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.